Dr. Addi S. Abuelshar, MD

Dr. Abuelshar practices at Jackson County Memorial Hospital in Altus, Oklahoma, part of Jackson County Memorial Hospital.

Dr. Abuelshar's NPI, 1295721678, was assigned on September 21, 2005. Dr. Abuelshar holds Oklahoma license 20057.

Dr. Abuelshar's primary practice is Jackson County Memorial Hospital, at 1200 East Pecan St, Altus, OK 73521 in Jackson County. The practice phone is (580) 379-5500.

Dr. Abuelshar's primary practice is Jackson County Memorial Hospital in Altus, Oklahoma, part of Jackson County Memorial Hospital. Dr. Abuelshar is also affiliated with SSM Health St. Anthony Hospital - Oklahoma City. The medical group on file is Jackson County Memorial Hospital. Dmand AI also links Dr. Abuelshar to 3 more hospitals and 1 medical group, each named with a free account. Dr. Abuelshar's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abuelshar practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Abuelshar's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Abuelshar is licensed in Oklahoma.

CMS data shows 1,351 Medicare services from Dr. Abuelshar across 13 procedure codes in 2024, for 421 Medicare patients. Medicare paid $111,331 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 421 Medicare patients who saw Dr. Abuelshar in 2024. The largest group is 75 to 84, with 154 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abuelshar's median patient age at 64, with 58% women.

In 2024, Dr. Abuelshar wrote 254 Medicare Part D claims for 122 patients. 83% of them were for generic drugs. CMS names the drug for 108 of them, across 5 drugs with 11 or more claims each, at $12,279 in total drug cost. In 2023, CMS named 212 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Abuelshar for performance year 2024, reported through an alternative payment model (APM). Dr. Abuelshar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abuelshar as offering telehealth.

CMS Open Payments shows 2 general payments to Dr. Abuelshar from 2 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Heron Therapeutics, Inc. paid the most, $64.